Who is sponsoring NCT00264485?

NCT00264485 is sponsored by Alza Corporation, DE, USA.

What condition does NCT00264485 study?

NCT00264485 studies Pain, Postoperative, Analgesia.

What drugs are being tested in NCT00264485?

Interventions: E-TRANS Fentanyl hydrochloride; Morphine.

What is the status of NCT00264485?

NCT00264485 is currently COMPLETED.

Last reviewed 2011-05-18 · How we verify

Comparison of the Safety and Efficacy of Patient Controlled Analgesia Delivered by the E-TRANS Fentanyl HCl Transdermal System Versus Morphine IV Pump for Pain Management After Primary Unilateral Total Hip Replacement

NCT00264485 Phase 3 COMPLETED

The purpose of this study is to compare two pain medications delivered by two different forms of patient-controlled analgesia (PCA) management systems: the Fentanyl HCl Patient-Controlled Transdermal System (E-TRANS fentanyl) and the morphine intravenous pump. Fentanyl HCl and morphine are narcotic pain relievers. The E-TRANS fentanyl system is a small unit worn on the patient's upper outer arm or chest that uses low-intensity electrical current to deliver fentanyl through the skin and into the patient's bloodstream. The patients studied will be those who have just received a total hip replacement.

Details

Lead sponsor	Alza Corporation, DE, USA
Phase	Phase 3
Status	COMPLETED
Enrolment	799
Start date	2004-03
Completion	2005-04

Conditions

Pain, Postoperative
Analgesia

Interventions

E-TRANS Fentanyl hydrochloride; Morphine

Primary outcomes

Success (defined by a rating of "Excellent", or "Good") on the 24-hour patient global assessment of the method of pain control.